Lobbying intensity is a quantifiable investment factor
The guest argued that measuring a company's lobbying spend relative to its size is a powerful, quantifiable factor for predicting stock outperformance.
The argument
The speaker explained that companies with high 'lobbying intensity' build a defensive presence in Washington that helps them navigate regulatory risks and secure policy wins. They contrasted proactive lobbyist Eli Lilly with Gilead, which suffered regulatory pushback after failing to lobby effectively.
The thesis, stress-tested
✓ What validates it
- ✓Favorable regulatory rulings or contract awards for high-lobbying-intensity firms
- ✓Outperformance of the SAGP ETF relative to the broader S&P 500
▸ Risks discussed
- ▸Bipartisan political shifts can occasionally target even the most heavily lobbied industries
- ▸Public backlash against corporate lobbying could lead to stricter disclosure rules or restrictions
Hear it yourself
"And what we figured out is that lobbying is a factor that could actually influence, returns. Companies go in and they lobby Washington with the idea that they're gonna get some sort of return on their investment."
00:00 / 00:14
AFFILIATE LINK · ZORTIX MAY EARN A COMMISSION · NEVER A RECOMMENDATION TO TRADE